How Much Did Miroculus Raise?
Funding & Key Investors

Miroculus, a San Francisco-based innovator in genomic automation, has secured significant capital, with its total funding reaching $48.2M and its most recent financing round amounting to $45M. This latest strategic investment underscores the company's progress in developing its novel digital microfluidics technology.

What is Miroculus?

Miroculus
Business ServicesResearch & DevelopmentManufacturing

Founded in 2014, Miroculus has engineered a compact and user-friendly system designed to automate and miniaturize complex genomic protocols. Their proprietary digital microfluidics technology is applicable across a range of critical life science applications, including Next-Generation Sequencing (NGS) library preparation, synthetic biology, cell editing, and combinatorial chemistry. This technological advancement aims to streamline laboratory workflows and accelerate research and development in the biotechnology sector.

How much funding has Miroculus raised?

Miroculus has raised a total of $48.2M across 3 funding rounds:

2015

Angel/Seed

$2.8M

2020

Debt

$350K

2021

Series B

$45M

Angel/Seed (2015): $2.8M, investors not publicly disclosed

Debt (2020): $350K led by PPP

Series B (2021): $45M supported by Section 32 and Cota Capital

Key Investors in Miroculus

Section 32

Section 32 is a venture capital firm that focuses on investing in cutting-edge technology, backed by a team with extensive experience in building iconic companies. Their investment strategy targets innovative startups and emerging technologies, aiming to support visionary entrepreneurs at the forefront of technological advancement.

Cota Capital

Cota Capital is an investment firm that focuses on early-stage technology companies addressing innovative challenges in the enterprise sector. They combine financial investment with deep operational expertise and industry insights to empower founders in building transformative businesses.

What's next for Miroculus?

The substantial enterprise-level funding, coupled with a recent strategic investment, positions Miroculus for accelerated growth and market penetration. This capital infusion is expected to fuel further development of their platform, expand their commercial reach, and potentially explore new applications for their microfluidics technology. The company's trajectory suggests a focus on scaling operations and solidifying its position as a key player in the genomics and biotechnology automation space.

See full Miroculus company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingHuman Resources Management Systems (HRMS)
Business ServicesCommercial Printing
Business ServicesResearch & DevelopmentAdvertising Networks
Business ServicesHuman Resources Management Systems (HRMS)

Frequently Asked Questions Regarding Miroculus Financial Insights

What are the most recent funding rounds that Miroculus has completed, and what were the funding rounds?
Miroculus has recently completed 3 funding rounds: Series B on Feb 25, 2021, Debt on Apr 27, 2020, Angel/Seed on Apr 7, 2015.
What is the total amount of funding Miroculus has raised to date?
Miroculus has raised a total of $48.2M in funding to date.
How many funding rounds has Miroculus completed?
Miroculus has completed 3 funding rounds.
How much funding did Miroculus raise in its most recent funding round?
Miroculus raised $45M in its most recent funding round.
Who are the lead investors in Miroculus's latest funding round?
The lead investor in Miroculus's latest funding round was Section 32. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Miroculus's history?
The largest funding round in Miroculus's history was $45M.
See more information about Miroculus